Clinical Trial Update: OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of phentolamine ophthalmic solution for participants with decreased mesopic visual acuity after keratorefrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vision Disorders
• Vision Loss

Drugs mentioned

• Phentolamine Ophthalmic Solution (phentolamine)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Vision Loss Night, Vision Disorders | Phase 3 | Status: ACTIVE_NOT_RECRUITING